✦ LIBER ✦

O-49 A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer

✍ Scribed by S. Chan; R. Sharma; G. Romieu; T. Huober; T. Delozier; M. Tubiana-Hulin; A. Schneeweiss; A. Lluch; A. Llombart; A. du Bois; E. Carrasco; A. Thareau; P. Fumoleau

Book ID: 118626005
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 54 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71739-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus docetaxel versus capeci

Gemcitabine plus docetaxel versus capecitabine plus docetaxel forpatients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial

✍ Stephen Chan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 476 KB

A multicenter phase II trial of docetaxe

A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer

✍ N. Karachaliou; Ch. Kouroussis; P. Papakotoulas; K. Kalbakis; K. Tryfonidis; N. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 194 KB

Concomitant docetaxel plus gemcitabine v

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

✍ Antoaneta Tomova; Rupert Bartsch; Thomas Brodowicz; Valentina Tzekova; Constanta 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 277 KB